Research and Development Trend Forecast of Chinese Patent Medicine in China, 2014-2018 analyses the policy environment, market scale, competition pattern, development trend and key enterprises in Chinese patent medicine industry in China. The implement of New Medical Reform Plan provides solid guarantee for the development of Chinese patent medicine, but also National Essential Drugs List lists large batch of Chinese Patent Medicine, which drives the continual expansion of Chinese patent medicine market scale in China effectively. In 2009, the cumulative output of Chinese patent medicine was 1.8037 million ton, since 2010, the Chinese patent medicine industry has been maintaining fast growth, the cumulative output was 1.9977 million ton in 2010 and 3.1052 million ton in 2013. With the era development, the health concept has been given new connotation, the third state (Sub-health state) and its harm has cause people’s extensive concerns; and with the improvement of living standard, people long for life quality and long life increasingly. Human medical model has been transformed from the pure “biomedical model” to the “biological-psychology-sociological... Research Beam Model: Research Beam Product ID: 159834 1800 USD New
Research and Development Trend Forecast of Chinese Patent Medicine in China, 2014-2018

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Research and Development Trend Forecast of Chinese Patent Medicine in China, 2014-2018

 
  • Category : Pharmaceuticals
  • Published On : September  2014
  • Pages : 62
 
 
Research and Development Trend Forecast of Chinese Patent Medicine in China, 2014-2018 analyses the policy environment, market scale, competition pattern, development trend and key enterprises in Chinese patent medicine industry in China.

The implement of New Medical Reform Plan provides solid guarantee for the development of Chinese patent medicine, but also National Essential Drugs List lists large batch of Chinese Patent Medicine, which drives the continual expansion of Chinese patent medicine market scale in China effectively. In 2009, the cumulative output of Chinese patent medicine was 1.8037 million ton, since 2010, the Chinese patent medicine industry has been maintaining fast growth, the cumulative output was 1.9977 million ton in 2010 and 3.1052 million ton in 2013.

With the era development, the health concept has been given new connotation, the third state (Sub-health state) and its harm has cause people’s extensive concerns; and with the improvement of living standard, people long for life quality and long life increasingly. Human medical model has been transformed from the pure “biomedical model” to the “biological-psychology-sociological model”, and from treatment of disease to the model combining prevention, health, treatment and recovery.

The chemical drugs bite off more than they can chew in this field, while the profound Chinese patent medicine are causing people’s attention and playing important role in health increasingly, and the rush of health cult provides valuable opportunities and extensive space for Chinese patent medicine development in China.
1. Overview of Chinese Patent Medicine
1.1 Concept
1.2 Product Classification

2. Development Environment of Chinese Patent Medicine in China
2.1 Economic Development Environment in China
2.2 Related Industrial Policies, Law, Regulations and Standards
2.2.1 Influence on Chinese Patent Medicine by New Medical Reform Policy
2.2.2 Chinese Patent Medicine Development in “the 12th Five Years Plan” Period
2.2.3 Policy Summary of Medicine Industry in China
2.2.4 Related Industrial Standards
2.3 Many Countries with Restriction on Sales of Chinese Patent Medicine

3. Current Status of Chinese Patent Medicine Industry in China
3.1 Development History
3.2 Current Status of Overall Development
3.2.1 Current Status of Chinese Patent Medicine Development in China
3.2.2 Current Status of Chinese Patent Medicine Trade in China
3.3 Competition Pattern in Chinese Patent Medicine Industry

4. Analysis and Forecast on Chinese Patent Medicine Market Scale in China
4.1 Output
4.1.1 Output Analysis
4.1.2 Output Forecast
4.2 Sales
4.2.1 Sales Analysis
4.2.2 Sales Structure in 2013
4.2.3 Sales Forecast
4.3 Market Segmentation
4.3.1 Cardio-cerebrovascular Diseases
4.3.2 Tumor diseases
4.3.3 Respiratory Diseases
4.3.4 Bone Diseases

5. Analysis on Import and Export of Chinese Patent Medicine in China
5.1 Import Volume and Value in 2011- the First Half Year of 2014
5.2 Export Volume and Value in 2011- the First Half Year of 2014
5.3 Main Import Sources and Export Destinations by Trade Value in the First Half Year of 2014

6. Main Chinese Patent Medicine Enterprises in China
6.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd
6.1.1 Company Profile
6.1.2 Competitiveness
6.1.3 Business Performance
6.1.4 Development Strategy
6.1.5 Main Business and Products
6.2 Jilin Xiuzheng Pharmaceutical Group
6.2.1 Company Profile
6.2.2 Competitiveness
6.2.3 Business Performance
6.2.4 Main Products
6.3 Yangtze River Pharmaceutical Group
6.3.1 Company Profile
6.3.2 Competitiveness
6.3.3 Business Performance
6.3.4 Development Strategy
6.3.5 Main Products
6.4 Chongqing Taiji Industry (Group) Co., Ltd
6.4.1 Company Profile
6.4.2 Competitiveness
6.4.3 Business Performance
6.4.4 Development Strategy
6.4.5 Main Products
6.5 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd
6.5.1 Company Profile
6.5.2 Competitiveness
6.5.3 Business Performance
6.5.4 Development Strategy
6.5.5 Main Business and Products

7. Future Development Trend of Chinese Patent Medicine in China

8. Expert Suggestion on investment in Chinese Patent Medicine Industry
8.1 SWOT Analysis
8.2 Market Strategy Analysis